PMID: 15332212Aug 28, 2004Paper

High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Félix CantarovichHigh-Dose Flurosemide in Acute Renal Failure Study Group

Abstract

The effect of furosemide on the survival and renal recovery of patients presenting with acute renal failure (ARF) is still debated. Three hundred thirty-eight patients with ARF requiring dialysis therapy were randomly assigned to the administration of either furosemide (25 mg/kg/d intravenously or 35 mg/kg/d orally) or matched placebo, with stratification according to severity at presentation. The primary end point was survival. The secondary end point was number of dialysis sessions. Tertiary end points included time on dialysis therapy, time to achieve a serum creatinine level less than 2.26 mg/dL (<200 micromol/L), and time to reach a 2-L/d diuresis. There were no differences in survival and renal recovery rates between the 2 groups. Time to achieve a 2-L/d diuresis was shorter with furosemide (5.7 +/- 5.8 days) than placebo (7.8 +/- 6.8 days; P = 0.004). Overall, 148 patients achieved a urine output of at least 2 L/d during the study period (94 of 166 patients; 57%) with furosemide versus 54 of 164 patients (33%) with placebo ( P < 0.001). However, there were no significant differences in number of dialysis sessions and time on dialysis therapy between the furosemide and placebo groups, even in the subgroup of patients reac...Continue Reading

Citations

May 21, 2013·Journal of Critical Care·Fahad AlqahtaniBertrand L Jaber
Dec 26, 2012·Advances in Chronic Kidney Disease·Annie-Claire Nadeau-Fredette, Josée Bouchard
Mar 1, 2012·Kidney International Supplements
Nov 22, 2011·Seminars in Nephrology·Sagar U Nigwekar, Sushrut S Waikar
Jan 14, 2011·Néphrologie & thérapeutique·Mohamed MiguilRamdani Benyounes
Oct 16, 2009·Critical Care Medicine·Paula DennenRobert Anderson
Apr 11, 2008·Critical Care Medicine·Sean M BagshawJohn A Kellum
Jul 16, 2008·Seminars in Nephrology·Saroj K Mishra, Bhabani Shankar Das
Jul 17, 2014·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Shinici Nishi
Jan 24, 2007·Anesthesiology Clinics·Gebhard Wagener, Tricia E Brentjens
Dec 5, 2012·Acta Paediatrica·Deirdre U SweetmanEleanor J Molloy
Oct 14, 2011·Acta Physiologica·A-A M HusseinH Abol-Enein
Jan 21, 2010·Anaesthesia·K M Ho, B M Power
Mar 23, 2005·Critical Care Clinics·Paul M Palevsky
Feb 22, 2011·Transplantation Proceedings·C MonsalveA Alcaraz
Aug 4, 2016·BMC Nephrology·Rolando Claure-Del Granado, Ravindra L Mehta
Sep 8, 2016·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·David E Leaf, Sushrut S Waikar
Dec 12, 2012·Interactive Cardiovascular and Thoracic Surgery·Seyed Mohsen MirhosseiniMohammad Reza Masjedi
Sep 12, 2014·British Journal of Anaesthesia·S GoldsteinUNKNOWN ADQI XII Investigators Group
Jun 8, 2018·Anesthesiology·Nishkantha Arulkumaran, John R Prowle
Nov 4, 2006·Transplant International : Official Journal of the European Society for Organ Transplantation·Peter Schnuelle, Fokko Johannes van der Woude
Nov 2, 2006·Current Opinion in Critical Care·Sean M Bagshaw
Apr 7, 2007·Current Opinion in Anaesthesiology·Dean R Jones, H Thomas Lee
Oct 13, 2007·Der Anaesthesist·C Putensen
Apr 1, 2005·Current Opinion in Pediatrics·Prasad Devarajan
Jun 11, 2008·Drugs & Aging·Ching M CheungJohn G Anderton
Nov 13, 2008·Paediatric Drugs·Sharon P Andreoli
Dec 17, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Sharon Phillips Andreoli
Aug 27, 2009·International Urology and Nephrology·Rahmi Yilmaz, Yunus Erdem
May 19, 2006·Journal of the American Society of Nephrology : JASN·Prasad Devarajan
Jan 25, 2006·Acta Anaesthesiologica Scandinavica·J H Laake, J F Bugge
Apr 14, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Bertrand DussolYvon Berland
Feb 1, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Claudio RoncoAndrew A House
Aug 21, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Kathleen D LiuGlenn M Chertow
Mar 3, 2011·Nature Reviews. Nephrology·Zaccaria RicciClaudio Ronco
May 8, 2013·Nature Reviews. Nephrology·Mark A Perazella, Steven G Coca
Dec 25, 2009·Renal Failure·Maria O N AvilaEmmanuel A Burdmann
Jul 31, 2013·Clinical and Experimental Nephrology·Iwao OhnoUNKNOWN Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Science Advisory and Coordinati

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
I R ShillidayM E Allison
Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)
A Medina VillanuevaF Santos Rodríguez
© 2021 Meta ULC. All rights reserved